Robert Califf got 89 votes in the Senate last time – but that’s also the least a Democratic nominee has ever gotten.
The nomination of Robert Califf to be commissioner of the US Food and Drug Administration sets off the confirmation process in the Senate: a committee hearing, a committee vote, and then a vote on the floor.
He’s been through this before, and cleared each hurdle, if not terribly quickly. With the Senate then in Republican hands...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
